Hemolytic uremic syndrome (HUS) as a rare complication of induction chemotherapy for acute myeloid leukemia (AML) without maturation

IR Web Site

Bibliographic Information

Other Title
  • 急性骨髄性白血病寛解導入療法後に発症した溶血性尿毒症性症候群の１例
  • キュウセイ コツズイセイ ハッケツビョウ カンカイ ドウニュウ リョウホウゴ ニ ハッショウ シタ ヨウケツセイ ニョウドクショウセイ ショウコウグン ノ 1レイ

Search this article

Description

論文(Article)

A 75-year-old male was diagnosed with acute myeloid leukemia without maturation and was treated with combination chemotherapy. After the first remission-induction therapy, he reached complete remission. About one month after the first induction therapy, he was diagnosed with a complication of chemotherapy-related HUS (C-HUS). He gradually recovered from the C-HUS after the initiation of a plasma exchange. In conclusion, it seems that the anti-leukemic drugs might play an important role in the development of chemotherapy C-HUS.

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top